Electrophysiology Ablation Market by Size | Growth | Analysis | Trends and Forecasts to 2022-2030Posted by sandeep gade on October 20th, 2022 According to a recent study by Persistence Market Research, the global electrophysiology ablation market is expected to witness high growth from US$ 2.5 Bn in 2021 to US$ 6.3 Bn by 2031. This reflects a CAGR of around 8.4% over the forecast period (2021-2031). Rising morbidity and mortality due to cardiac disorders, especially arrhythmia, make this market more demanding. Moreover, new product innovation and increased adoption of electrophysiology ablation devices by cardiologists in hospitals is expected to boost market growth over the forecast period. The market is experiencing drastic changes with high adoption of electrophysiology ablation procedures due to rising awareness about cardiac health. Sales and marketing practices by some manufacturers are influencing the procedure and device cost in selective regions. Additionally, rising investments in the healthcare sector in emerging regions and reimbursement policies for cardiac ablation are further expected to give positive growth to this market. Technological innovations are warranted to improve the safety and effectiveness of ablation devices, thereby helping market growth. Significant growth has been observed in two of the most dynamic segments: cardiac rhythm management (CRM) and electrophysiology (EP) segment, in recent years. Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/25474 From the last few years, there has been considerable progress and innovation made in developing advances in heart rhythm therapy. Ongoing researches in this segment will help create the landscape for further product advancement in the electrophysiological ablation market. As the market is consolidated in terms of catheters being used, market leaders are focusing on increasing their product portfolios to strengthen their product acceptability at the end user level globally.
Leading players are focusing on investment in developing countries to increase their foothold in the market. Also, major market players have been concentrating on enhancing gains through advancements in distribution channels. Company Profiles:
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/25474 Key Takeaways from Market Study
“Increasing adoption of technologically advanced devices and growing awareness about cardiac disorder and associated risks are expected to drive demand for electrophysiology ablation over the decade,” says a Persistence Market Research Analyst. Who is Winning? Major manufacturers of electrophysiology ablation devices have been focusing on product launches, collaborations, and partnerships for global expansion.
Major market players covered in the report include Biosense Webster (Johnson & Johnson), Abbott Laboratories, MEDTRONIC PLC, Boston Scientific Corporation, CathRx Ltd, Biotronik SE & Co. KG., Japan Lifeline Co, ATRICURE, INC., Auris Health, and Biomerics. Access Full Report@ https://www.persistencemarketresearch.com/checkout/25474 What Else is in the Report? Persistence Market Research offers a unique perspective and actionable insights on electrophysiology ablation market in its latest study, presenting historical demand assessment of 2016 – 2020 and projections for 2021–2031, based on product (diagnostic catheters, ablation catheters, and access devices), application (supraventricular tachycardia (SVT) ablation, ventricular tachycardia(VT/VPC), and atrial fibrillation (AF)), and end user (hospitals, ambulatory surgical centers, and clinics), across seven key regions of the world. About Us: Persistence Market Research Contact Us: Persistence Market Research Like it? Share it!More by this author |